Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
While the pathogenesis of
amyotrophic lateral sclerosis
(
ALS
) remains to be clearly delineated, there is mounting evidence that altered RNA metabolism is a commonality amongst several of the known genetic variants of the disease. In this study, we evaluated the expression of 10
ALS
-associated proteins in spinal motor neurons (MNs) in
ALS
patients with mutations in C9orf72 (C9orf72(GGGGCC)-
ALS
; n = 5), SOD1 (mtSOD1-
ALS
; n = 9), FUS/TLS (mtFUS/TLS-
ALS
; n = 2), or TARDBP (mtTDP-43-
ALS
; n = 2) and contrasted these to cases of sporadic
ALS
(sALS; n = 4) and familial
ALS
without known mutations (fALS; n = 2). We performed colorimetric immunohistochemistry (IHC) using antibodies against TDP-43, FUS/TLS, SOD1, C9orf72, ubiquitin, sequestosome 1 (p62), optineurin, phosphorylated high molecular weight neurofilament, peripherin, and
Rho-guanine nucleotide exchange factor
(
RGNEF
). We observed that
RGNEF
-immunoreactive neuronal cytoplasmic inclusions (NCIs) can co-localize with TDP-43, FUS/TLS and p62 within spinal MNs. We confirmed their capacity to interact by co-immunoprecipitations. We also found that mtSOD1-
ALS
cases possess a unique IHC signature, including the presence of C9orf72-immunoreactive diffuse NCIs, which allows them to be distinguished from other variants of
ALS
at the level of light microscopy. These findings support the hypothesis that alterations in RNA metabolism are a core pathogenic pathway in
ALS
. We also conclude that routine IHC-based analysis of spinal MNs may aid in the identification of families not previously suspected to harbor SOD1 mutations.
...
PMID:Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. 2294 Dec 24